• Magyar
  • English
Egyéb kategória
  • We are still waiting for our members’ suggestions regarding the possible recipients of the “Béla Issekutz Memorial Medal” and the Knoll-Szolcsányi Award. If you would like to nominate someone for the recognition, please send their name to the e-mail address [email protected] (copy to Prof. Dr. Péter Ferdinandy, President and Prof. Dr. Zsuzsanna Helyes, Secretary General).

  • The goal of the Experimental Section is to coordinate and to facilitate the active participation of experimental pharmacologists at national and international meetings, and to organize scientific conference sessions. The Section assists in the development of the international professional connections for junior pharmacologists. In addition, it is our goal to improve communication between experimental professionals Tovább …

  • The Education Section of HUPHAR aims to harmonize the undergraduate pharmacology education programs of Hungarian medical universities, with special regard to strengthening clinical pharmacology in accordance with international trends and the guidelines of partner organizations. Our further goal is to display undergraduate and graduate degree programs and topics in social media, thereby promoting pharmacology as Tovább …

  • Division of Pharmacokinetics and Drug-metabolism is the major platform for scientists and experts in the academic sector and pharmaceutical industry. The program of the Division comprises the fields of drug pharmacokinetics, enzymes and transporter proteins in drug-metabolism as well as of novel in vitro and in vivo models, new analytical approaches and improvements in guides Tovább …

  • The mission of Hungarian Section for Extracellular Vesicles (HSEV) is to facilitate networking of the Hungarian researchers in the field of extracellular vesicle research by organizing conferences, professional forums, workshops, discussions, and joint review publications. The HSEV also aims to represent the interests of Hungarian EV research community nationally and internationally, providing a common platform Tovább …

  • 2020 I. Ladányi Lászlóné Déri Szilvia: Impaired cytoplasmic domain interactions cause co-assembly defect and loss of function in the p.Glu293Lys KNCJ2 variant isolated froman Andersen–Tawil syndrome patient II. Gömöri Kamilla: Cardioprotective Effect of Novel Matrix Metalloproteinase Inhibitors III. Hajna Zsófia: Complex Regulatory Role of the TRPA1 Receptor in Acute and Chronic Airway Inflammation Mouse Models

  • According to its Statues, our Society may bestow the “Béla Issekutz commemorative medal” on a scientist for his/her achievements. The General Assembly decides on the award on the proposal of the Executive Board. The award will be presented at the Annual General Assembly, at which time the name of the next year’s winner will also be Tovább …

  • The section reinforces the molecular and multidisciplinary approach essential to almost all areas of pharmacology and drug innovation. In this context, but also beyond, it presents the practices and perspectives of state-of the art data utilization and data science, and supports the application of data analysis methods to health care and health industry.

  • The Immunopharmacology section of HUPHAR deals with innovative medicines in the field of immunology and inflammatory diseases. We regularly follow the recent developments, especially with respect to targeted therapies. We confer up-to-date information on these novel agents at scientific conferences and postgraduate courses.

  • The aim of the Pharmaceutical Medicine Section of the Hungarian Experimental and Clinical Pharmacology Society is to support the research, clinical development and scientifically based marketing of medicines. It encourages the scientific cooperation of clinical and industrial developers for continuously improving the effectivity of drug therapy.